Similarly, in every age group (except 41–45 years) with patients having >12 IU/L bFSH, the clinical pregnancy rate and live birth rate treated by AIH were significantly lower than those in the IVF/ICSI group. This evidence concerns the gene FSHB and autoimmune hepatitis.